Huons Global Co., Ltd. (KOSDAQ:084110)
South Korea
· Delayed Price · Currency is KRW 57,500
+3,300 (6.09%)
At close: Dec 5, 2025
Huons Global Revenue
Huons Global had revenue of 211.17B KRW in the quarter ending September 30, 2025, with 5.89% growth. This brings the company's revenue in the last twelve months to 825.44B, up 1.78% year-over-year. In the year 2024, Huons Global had annual revenue of 813.46B with 7.26% growth.
Revenue (ttm)
825.44B
Revenue Growth
+1.78%
P/S Ratio
0.85
Revenue / Employee
7.00B
Employees
118
Market Cap
701.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 813.46B | 55.08B | 7.26% |
| Dec 31, 2023 | 758.38B | 94.01B | 14.15% |
| Dec 31, 2022 | 664.36B | 89.72B | 15.61% |
| Dec 31, 2021 | 574.65B | 51.60B | 9.87% |
| Dec 31, 2020 | 523.05B | 73.62B | 16.38% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |